Education
Dr. McCollum received a B.B.A. with honors from The University of Texas at Austin in 1991. He received his M.D. from The University of Southwestern Medical School in Dallas, Texas in 1995. He served as Chief Medicine Resident at U.T. Southwestern Medical Center in 1998-1999, and in 2000 he completed a Clinical Effectiveness Program at the Harvard School of Public Health in Boston, MA. He completed his clinical and research fellowships in Hematology and Medical Oncology at the Dana-Farber Cancer Institute and Partners Cancer Care Training Program (Boston, MA) in 2002. During his training at the Dana-Farber Cancer Institute in Boston, he was the recipient of the Noah T. Herndon Fellowship and the Irving W. Janock Fellowship in GI Malignancies.
Accolades & Memberships
American Medical Association, Texas Medical Association, Dallas County Medical Society, American Society of Clinical Oncology, Massachusetts Medical Society, and Alpha Omega Alpha Honor Medical Society. Recipient of a 2001 Merit Award from the American Society of Clinical Oncology for research presented at the annual meeting.
Publications
-
Phase II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer and/or Adenocarcinoma of the Gastroesophageal Junction
Annals of Oncology, 2008
-
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004
Proc (Bayl Univ Med Cent), 2006
-
The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer
American Journal of Clinical Oncology, 2006
-
A Phase II Study of Gemcitabine Plus Zoledronic Acid in Stage IV Cancer of the Pancreas
ASCO Gastrointestinal Cancers Symposium, 2006
Show less publications